Comparison of quantitative internal and external measures of performance for trainees in cytopathology fellowships.


Journal

Journal of the American Society of Cytopathology
ISSN: 2213-2945
Titre abrégé: J Am Soc Cytopathol
Pays: United States
ID NLM: 101613234

Informations de publication

Date de publication:
Historique:
received: 02 04 2021
revised: 04 05 2021
accepted: 10 05 2021
pubmed: 9 6 2021
medline: 19 2 2022
entrez: 8 6 2021
Statut: ppublish

Résumé

Cytopathology fellowships need measures to assess performance of fellows. We sought to compare several internal quantitative assessment metrics in our fellowship with external metrics, such as performance on the American Society of Cytopathology (ASC) Progressive Evaluation of Competency (PEC) examination and United States Medical Licensing Examination (USMLE). Quantitative parameters generated from our laboratory information system (LIS) on cytopathology fellows were evaluated over 6 years, including case volume and diagnostic discrepancies, in addition to ASC PEC and USMLE scores. For discrepancy reports, interpretations made by the fellow were compared with that of the cytopathologist, and classified as none (concordant), minor (<2-levels) or major (≥2-levels). We evaluated internal and external metrics on 13 fellows over 6 years. The program average diagnostic concordance rate was 89.9%, with an average major discrepancy rate of 1.5%, and an average monthly case volume of 260 cases. More fellows with above-average ASC PEC performance showed above-average concordant diagnoses and lower case volume, while below-average PEC scores were seen more often with higher major discrepancy rates. More fellows with above-average USMLE scores had higher case volumes, while low USMLE scores showed a trend towards higher major discrepancy rates. Our fellowship program has used a variety of internal and external measures of performance for cytopathology fellows. Although the findings show no statistically significant finding correlating performance, these quantitative parameters generated from our LIS were helpful to identify areas of improvement, facilitate comparison to peers, and provide case volume documentation.

Identifiants

pubmed: 34099427
pii: S2213-2945(21)00050-8
doi: 10.1016/j.jasc.2021.05.003
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-503

Informations de copyright

Copyright © 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Juan Xing (J)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: xingj@upmc.edu.

Samer N Khader (SN)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

N Paul Ohori (NP)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Marie DeFrances (M)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Jackie Cuda (J)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Sara E Monaco (SE)

Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH